Fujita and colleagues assessed anti-tumour immunity at days 0, 12, and 28 of each cycle reporting an increased serum anti-HVJ-E antibody titre, whereas IL-6, IFN-α/β, and IFN-γ serum levels, and NK cell activity showed no significative changes [104]. This evidence concerns the gene IFNA1 and neoplasm.